OSHA Issues First-Ever Workplace Opioid Overdose Guidance

The Occupational Safety and Health Administration released a fact sheet on September 25, 2026, that marks the first time the federal workplace safety agency has issued specific guidance on preparing for and responding to opioid overdoses at work. The document arrives as drug overdoses account for roughly 8 percent of all workplace fatalities and only 28 percent of employers report keeping naloxone on-site, according to National Safety Council surveys.

The guidance does not create new compliance requirements. Instead, it offers a practical framework for employers who want to add overdose response to their existing emergency preparedness programs.

What the Guidance Covers

OSHA's fact sheet walks through the basics of recognizing an opioid overdose: slow or stopped breathing, blue lips or skin, pinpoint pupils, and unresponsiveness. It recommends keeping naloxone or nalmefene — the two medications that can reverse an opioid overdose — in visible, accessible locations such as near first-aid kits or automated external defibrillators. Employers are urged to train workers on whichever formulation they stock, whether nasal spray or injectable, and to check expiration dates and storage instructions regularly.

The document stresses a step that is often missed in the chaos of an emergency: call 911 immediately, even if reversal medication is administered and the person regains consciousness. Naloxone's effects can wear off before the opioid does, and additional medical care is frequently necessary.

A New Standard for Workplace First Aid

The OSHA fact sheet landed one week after a related update to the voluntary workplace first-aid standard. On September 17, ANSI and ISEA published ANSI/ISEA Z308.1-2026, which for the first time identifies naloxone as a supplemental supply that employers can consider when evaluating their workplace risks. The revision also adds guidance for training personnel in first aid, CPR, and AED use.

OSHA frequently refers employers to the ANSI/ISEA consensus standard when evaluating first-aid supplies, so the inclusion of naloxone carries weight even though compliance remains voluntary. The National Safety Council noted that the update is especially relevant at worksites where emergency medical services may not arrive immediately, a category that includes construction sites, warehouses, remote facilities, and many small businesses.

The gap between need and readiness is substantial. The NSC's data show that drug overdoses now cause about one in twelve workplace deaths, yet fewer than three in ten employers have naloxone available. The new guidance and standard revision give safety managers a reference point they have lacked until now.

For workers and employers navigating the ongoing opioid crisis, the guidance offers a starting point rather than a mandate. But in a landscape where fentanyl exposure can happen anywhere, the distinction between a workplace and a public health setting is increasingly blurred. Having reversal medication within arm's reach, and staff who know how to use it, is becoming as basic a precaution as fire extinguishers and first-aid kits. For those struggling with opioid addiction, workplace-based harm reduction measures add one more layer of protection in an environment where help may not arrive in time.